Live Breaking News & Updates on He Aura Us05153u1079

Stay updated with breaking news from He aura us05153u1079. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan (AU-011) for the Treatment of Non-Muscle Invasive Bladder Cancer

Aura Biosciences, Inc. , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, today announced that the U.S. Food. | June 30, 2022 ....

United Kingdom , Aura Biosciences Inc , Drug Administration , Exchange Commission , Head Of Regulatory Affairs Aura , Division Of Oncology , Aura Biosciences , Fast Track , Non Muscle Invasive Bladder Cancer , Priority Review , Mark De Rosch , Chief Operating Officer , Regulatory Affairs , Cadmus Rich , Chief Medical Officer , Orphan Drug , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Nc Stock Exchange , Press Release , He Aura Us05153u1079 ,